BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38632615)

  • 21. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
    Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q
    Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549
    [No Abstract]   [Full Text] [Related]  

  • 22. Systemic transcriptome analysis of hepatocellular carcinoma.
    Yu CB; Zhu LY; Wang YG; Li F; Zhang XY; Dai WJ
    Tumour Biol; 2016 Oct; 37(10):13323-13331. PubMed ID: 27460080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
    Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP
    Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.
    Liu M; Yan Q; Sun Y; Nam Y; Hu L; Loong JH; Ouyang Q; Zhang Y; Li HL; Kong FE; Li L; Li Y; Li MM; Cheng W; Jiang LX; Fang S; Yang XD; Mo JQ; Gong YF; Tang YQ; Li Y; Yuan YF; Ma NF; Lin G; Ma S; Wang JG; Guan XY
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6103-6113. PubMed ID: 32123069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma.
    Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J
    Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets.
    Lee JS; Thorgeirsson SS
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S51-5. PubMed ID: 15508103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.
    Villanueva A; Hoshida Y; Battiston C; Tovar V; Sia D; Alsinet C; Cornella H; Liberzon A; Kobayashi M; Kumada H; Thung SN; Bruix J; Newell P; April C; Fan JB; Roayaie S; Mazzaferro V; Schwartz ME; Llovet JM
    Gastroenterology; 2011 May; 140(5):1501-12.e2. PubMed ID: 21320499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.
    Melis M; Diaz G; Kleiner DE; Zamboni F; Kabat J; Lai J; Mogavero G; Tice A; Engle RE; Becker S; Brown CR; Hanson JC; Rodriguez-Canales J; Emmert-Buck M; Govindarajan S; Kew M; Farci P
    J Transl Med; 2014 Aug; 12():230. PubMed ID: 25141867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.
    Zhu HR; Huang RZ; Yu XN; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Dong L; Janssen HLA; Shen XZ; Zhu JM
    Tohoku J Exp Med; 2018 Jun; 245(2):89-98. PubMed ID: 29899182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.
    Aravalli RN; Talbot NC; Steer CJ
    World J Gastroenterol; 2015 Feb; 21(7):2011-29. PubMed ID: 25717234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results.
    Taouli B; Hoshida Y; Kakite S; Chen X; Tan PS; Sun X; Kihira S; Kojima K; Toffanin S; Fiel MI; Hirschfield H; Wagner M; Llovet JM
    Eur Radiol; 2017 Nov; 27(11):4472-4481. PubMed ID: 28439654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of
    Ming XL; Feng YL; He DD; Luo CL; Rong JL; Zhang WW; Ye P; Chai HY; Liang CZ; Tu JC
    Epigenomics; 2019 Aug; 11(10):1209-1231. PubMed ID: 31339046
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.
    Hu B; Yang XB; Sang XT
    Int Immunopharmacol; 2021 Jan; 90():107164. PubMed ID: 33172741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma.
    Ivanovska I; Zhang C; Liu AM; Wong KF; Lee NP; Lewis P; Philippar U; Bansal D; Buser C; Scott M; Mao M; Poon RT; Fan ST; Cleary MA; Luk JM; Dai H
    PLoS One; 2011; 6(9):e24582. PubMed ID: 21949730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
    Moldogazieva NT; Zavadskiy SP; Terentiev AA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy.
    Erstad DJ; Fuchs BC; Tanabe KK
    Cancer; 2018 Aug; 124(15):3084-3104. PubMed ID: 29663340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
    Yu LX; Zhang BL; Yang Y; Wang MC; Lei GL; Gao Y; Liu H; Xiao CH; Xu JJ; Qin H; Xu XY; Chen ZS; Zhang DD; Li FG; Zhang SG; Liu R
    Oncol Rep; 2019 Jan; 41(1):257-269. PubMed ID: 30542726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.